ANI PHARMACEUTICALS INC (ANIP)
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
ANI Pharmaceuticals, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | 70.99 | 72.37 | 70.88 | 72.28 | 371,960 |
| Nov 2, 2026 | 72.21 | 72.92 | 70.66 | 70.67 | 514,718 |
| Oct 30, 2026 | 73.27 | 73.54 | 71.90 | 72.00 | 286,897 |
| Oct 29, 2026 | 72.68 | 73.62 | 72.05 | 73.16 | 262,411 |
| Oct 28, 2026 | 70.78 | 72.76 | 70.31 | 71.71 | 335,905 |
| Oct 27, 2026 | 72.18 | 72.41 | 70.73 | 71.17 | 285,234 |
| Oct 26, 2026 | 72.74 | 73.84 | 72.02 | 72.60 | 229,291 |
| Oct 23, 2026 | 73.30 | 73.42 | 72.05 | 72.61 | 318,598 |
| Oct 22, 2026 | 72.50 | 74.15 | 71.85 | 73.75 | 454,416 |
| Oct 21, 2026 | 72.44 | 73.51 | 71.80 | 72.24 | 345,033 |
| Oct 20, 2026 | 73.31 | 74.00 | 72.42 | 72.67 | 264,960 |
| Oct 19, 2026 | 72.41 | 73.21 | 72.32 | 72.56 | 253,639 |
| Oct 16, 2026 | 72.65 | 73.08 | 71.50 | 72.29 | 333,932 |
| Oct 15, 2026 | 71.08 | 73.19 | 71.02 | 72.28 | 240,988 |
| Oct 14, 2026 | 70.54 | 72.31 | 69.90 | 70.16 | 269,202 |
| Oct 13, 2026 | 73.59 | 73.59 | 70.44 | 70.84 | 331,804 |
| Oct 12, 2026 | 74.00 | 74.28 | 72.80 | 73.59 | 318,479 |
| Oct 9, 2026 | 71.87 | 74.43 | 71.25 | 73.89 | 540,837 |
| Oct 8, 2026 | 71.84 | 73.01 | 71.28 | 71.98 | 419,713 |
| Oct 7, 2026 | 71.77 | 72.74 | 71.57 | 71.93 | 438,193 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 CAREY STEPHEN P. | SVP & CFO | Sale | 2.9K | $207.7K | Oct 29, 2026 |
 Lalwani Nikhil | PRESIDENT & CEO | Sale | 5.4K | $388.2K | Oct 15, 2026 |
 Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $36.8K | Oct 13, 2026 |
| CAREY STEPHEN P. | SVP & CFO | Sale | 2.9K | $208.1K | Sep 29, 2026 |
| Lalwani Nikhil | PRESIDENT & CEO | Sale | 5.4K | $383.4K | Sep 15, 2026 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $35.4K | Sep 14, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 3.0M | 12.9% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Jul 2026 | 2.9M | 12.6% | 13G |
Meridian Venture Partners II GP, L.P. (\"GP\") · may incl. warrants· filed Aug 2025 | 1.0M | 4.4% | 13D |
Esjay LLC · may incl. warrants· stale · filed Jan 2024 | 932.6K | 4.1% | 13D |
Soleus Capital Management, L.P. | 867.8K | 3.8% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 838.2K | 3.6% | 13F |
STATE STREET CORP | 831.6K | 3.6% | 13F |
Millennium Management LLC · also on 13F· may incl. warrants· filed Apr 2025 | 818.3K | 3.6% | 13G |
TANG CAPITAL MANAGEMENT LLC | 707.5K | 3.1% | 13F |
DIMENSIONAL FUND ADVISORS LP | 623.5K | 2.7% | 13F |
Insiders
- CAREY STEPHEN P.SVP & CFO
- Lalwani NikhilPRESIDENT & CEO
- Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
- Thoma JeanneDirector
- Gosebruch Henry ODirector
- Gutwerg OriSVP, GENERICS
- HAUGHEY THOMASDirector
- Pera Antonio RDirector
- Leonard Matthew JDirector
- TANNENBAUM RENEE PDirector
Top institutional holders
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products.
The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
based on 22.97M shares outstanding
US30d Avg
338.87K
60d Avg
378.00K
90d Avg
393.54K